|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Keros Therapeutics (NASDAQ: KROS) through any online brokerage.
The latest price target for Keros Therapeutics (NASDAQ: KROS) was reported by SVB Leerink on December 8, 2020. The analyst firm set a price target for 80.00 expecting KROS to rise to within 12 months (a possible 112.31% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Keros Therapeutics (NASDAQ: KROS) is $37.68 last updated Today at 8:00:01 PM.
There are no upcoming dividends for Keros Therapeutics.
There is no upcoming split for Keros Therapeutics.
Keros Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.